• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Advisory Committees

  • Print
  • Share
  • E-mail

Slides for the March 19, 2009 Cardiovascular and Renal Drugs Advisory Committee

FDA Opening Remarks

Rafel (Dwaine) Rieves, M.D.

Director Division of Medical Imaging and Hematology Products,

CDER, OND, OODP [PDF]

 

FDA

Kathy Robie-Suh, M.D.

Medical Officer/Team Leader, Division of Medical Imaging and Hematology Products, CDER, OND, OODP [PDF]

 

Min Lu, M.D., M.P.H.

Medical Officer, Division of Medical Imaging and Hematology Products,

CDER, OND, OODP [PDF]

 

Qing Xu, Ph.D.

Statistical Reviewer, Office of Biostatistics, Division of Biometrics V [PDF]

 

Kate Gelperin, M.D., M.P.H.

Medical Officer, Office of Surveillance and Epidemiology, Division of Epidemiology I [PDF]

 

Christoffer W. Tornoe, Ph.D.

Division of Pharmacometrics, Office of Clinical Pharmacology [PDF]

 

Sponsor

 

Johnson & Johnson Pharmaceutical Research and Development, L.L.C. 

Core Presentation  [PDF]

 

Johnson & Johnson Pharmaceutical Research and Development, L.L.C.

Backup Files [PDF]

 

Open Public Hearing Speaker

 

Speaker #1 [PDF]